RQM+ provides deep regulatory and clinical expertise for in vitro diagnostic (IVD) manufacturers, with fully integrated support across EU IVDR and U.S. FDA requirements. From strategic planning through post-market performance follow-up (PMPF), our MedTech-only team helps de-risk development, accelerate submissions, and support global market success.
Why RQM+ for IVDs?
-
MedTech-Only CRO
100% focused on medical devices and diagnostics.
-
Regulatory and Clinical Integration
End-to-end alignment across regulatory strategy, clinical performance, and market access.
-
True IVDR Experts
Scientific validity, classification, PERs, and compliance with Annexes I, XIII, and XIV.
-
FDA Compliance
U.S. regulatory strategy aligned with 21 CFR Parts 807, 809, 812, 820, and more.
-
Life Cycle Support
From design through post-market surveillance and notified body audits.
Standards We Navigate
-
EU IVDR (Regulation EU 2017/746)
-
ISO 13485 – Quality Management Systems for Medical Devices
-
ISO 15189 – Medical Laboratories – Requirements for Quality and Competence
-
ISO 20916 – Clinical Performance Studies of IVDs
-
FDA 21 CFR Parts 11, 50, 56, 58, 807, 809, 812, 820
-
CLSI EP Series Guidelines (e.g., EP05, EP07, EP09)
-
GDPR and IVDR Article 61 – Data protection in EU clinical research
IVD Support Across the Total Product Life Cycle
Expand each to see our key services.
Flexible Partnering Solutions
Full-Service Outsourcing
End-to-end project ownership, from strategy to execution. Our managed outsourcing solutions enable easy collaboration, streamlined operations, and expert oversight so you can focus on what you do best.